The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation

FEBS Letters

Volumn 580, Issue 10, 2006, Pages 2503-2511

  Ren, Qing Guo ^a   Liao, Xiao Mei ^a,b   Wang, Ze Fen ^a   Qu, Zhong Shen ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CENTRAL CHINA NORMAL UNIVERSITY   (China)

Author keywords

Glycogen synthase kinase 3; Hyperphosphorylation; Proteasome; Protein phosphatase 2A; Tau

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; LACTACYSTIN; LITHIUM CHLORIDE; PACLITAXEL; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEASOME; SERINE; TAU PROTEIN;

ARTICLE; BIOACCUMULATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS;

ACETYLCYSTEINE; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; TAU PROTEINS;

EID: 33646083672     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.03.073     Document Type: Article

References (50)

1. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
2. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
3. Drewes G., Ebneth A., and Mandelkow E.M. MAPs, MARKs and microtubule dynamics. Trends Biochem. Sci. 23 (1998) 307-311
4. Friedhoff P., von Bergen M., Mandelkow E.M., and Mandelkow E. Structure of tau protein and assembly into paired helical filaments. Biochim. Biophys. Acta 1502 (2000) 122-132
5. Ferrer I., Gomez-Isla T., Puig B., Freixes M., Ribe E., Dalfo E., and Avila J. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr. Alzheimer Res. 2 (2005) 3-18
6. Iqbal K., Alonso A.C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., and Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739 (2005) 198-210
7. Tian Q., and Wang J. Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 11 (2002) 262-269
8. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., and Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000) 95-130
9. David D.C., Layfield R., Serpell L., Narain Y., Goedert M., and Spillantini M.G. Proteasomal degradation of tau protein. J. Neurochem. 83 (2002) 176-185
10. Cardozo C., and Michaud C. Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway. Arch. Biochem. Biophys. 408 (2002) 103-110
11. Delobel P., Leroy O., Hamdane M., Sambo A.V., Delacourte A., and Bue'e L. Proteasome inhibition and tau proteolysis: an unexpected regulation. FEBS Lett. 579 (2005) 1-5
12. Brown M.R., Bondada V., Keller J.N., Thorpe J., and Geddes J.W. Proteasome or calpain inhibition does not alter cellular tau levels in neuroblastoma cells or primary neurons. J. Alzheimer's Dis. 7 (2005) 15-24
13. Zhang, Y.J., Xu, Y.F., Liu, Y.H., Yin, J., Li, H.L., Wang, Q., and Wang, J.Z. Peroxynitrite induces Alzheimer-like tau modifications and accumulation in rat brain and its underlying mechanisms, FASEB J. (in press).
14. Kosik K.S., and Shimura H. Phosphorylated tau and the neurodegenerative foldopathies. Biochim. Biophys. Acta 1739 (2005) 298-310
15. Keller J.N., Hanni K.B., and Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75 (2000) 436-439
16. Lopez Salon M., Morelli L., Castano E.M., Soto E.F., and Pasquini J.M. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62 (2000) 302-310
17. Lopez Salon M., Pasquini L., Besio Moreno M., Pasquini J.M., and Soto E. Relationship between beta-amyloid degradation and the 26S proteasome in neural cells. Exp. Neurol. 180 (2003) 131-143
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
19. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., and Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10 (1993) 1089-1099
20. Merrick S.E., Trojanowski J.Q., and Lee V.M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17 (1997) 5726-5737
21. Liu S.J., Zhang A.H., Li H.L., Wang Q., Deng H.M., Netzer W.J., Xu H.X., and Wang J.Z. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J. Neurochem. 87 (2003) 1333-1344
22. Tanaka T., Zhong J., Iqbal K., Trenkner E., and Grundke-Iqbal I. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Lett. 426 (1998) 248-254
23. Tsujio I., Tanaka T., Kudo T., Nishikawa T., Shinozaki K., Grundke-Iqbal I., Iqbal K., and Takeda M. Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett. 469 (2000) 111-117
24. Gong C.X., Singh T.J., Grundke-Iqbal I., and Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 61 (1993) 921-927
25. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J.Q., and Lee V.M. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J. Biol. Chem. 269 (1994) 30981-30987
26. Ciechancver A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17 (1998) 7151-7160
27. de Vrij F.M., Fischer D.F., van Leeuwen F.W., and Hol E.M. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog. Neurobiol. 74 (2004) 249-270
28. Dziewulska D., and Rafalowska J. Proteinaceous intracellular inclusions in neurodegenerative disorders. Folia Neuropathol. 43 (2005) 51-63
29. Lopes U.G., Erhardt P., Yao R., and Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272 (1997) 12893-12896
30. Canu N., Barbato C., Ciotti M.T., Serafino A., Dus L., and Calissano P. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 20 (2000) 589-599
31. Pasquini L.A., Besio M., Adamo A.M., Pasquini J.M., and Soto E.F. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59 (2000) 601-611
32. Keller J.N., Gee J., and Ding Q. The proteasome in brain aging. Ageing Res. Rev. 1 (2002) 279-293
33. Shimura H., Schwartz D., Gygi S.P., and Kosik K.S. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279 (2004) 4869-4876
34. Goldbaum O., Oppermann Malte., Handschuh M., Dabir D., Zhang B., Forman M.S., Trojanowski J.Q., Lee V.M.Y., and Richter-Landsberg C. Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. J. Neurosci. 23 (2003) 8872-8880
35. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24 (2003) 441-443
36. Rice A.M., and Sartorelli A.C. Inhibition of 20 S and 26 S proteasome activity by lithium chloride. J. Biol. Chem. 276 (2001) 42722-42727
37. Szatmari E., Habas A., Yang P., Zheng J.J., Hagg T., and Hetman M. A positive feedback loop between glycogen synthase kinase 3β and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons. J. Biol. Chem. 280 (2005) 37526-37535
38. Theilade J., Hansen J.L., Haunso S., and Sheikh S.P. MAP kinase protects G protein-coupled receptor kinase 2 from proteasomal degradation. Biochem. Biophys. Res. Commun. 330 (2005) 685-689
39. Liu S., Premont R.T., Kontos C.D., Zhu S., and Rockey D.C. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat. Med. 11 (2005) 952-958
40. Cross D.A.E., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
41. Oliver C.J., and Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front Biosci. 3 (1998) 961-972
42. Tanimukai H., Grundke-Iqbal I., and Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am. J. Pathol. 166 (2005) 1761-1771
43. Li M., Guo H., and Damuni Z. Purification and characterization of two potent heat-stable inhibitor protein phosphatase 2A from bovine kidney. Biochemistry 34 (1995) 1988-1996
44. Bennecib M., Gong C.X., Grundke-Iqbal I., and Iqbal K. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett. 485 (2000) 87-93
45. Pei J.J., Gong C.X., An W.L., Winblad B., Cowburn R.F., Grundke-Iqbal I., and Iqbal K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am. J. Pathol. 163 (2003) 845-858
46. Kins S., Kurosinski P., Nitsch R.M., and Gotz J. Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am. J. Pathol. 163 (2003) 833-843
47. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
48. Doherty F.J., Dawson S., and Mayer R.J. The ubiquitin-proteasome pathway of intracellular proteolysis. Essays Biochem. 38 (2002) 51-63
49. Shringarpure R., Grune T., and Davies K.J. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells. Cell Mol. Life Sci. 58 (2001) 1442-1450
50. Coux O., Tanaka K., and Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65 (1996) 801-847